Drug

Picotamide

As of the edition of 20 October 2026, Picotamide is a small molecule: marketed; acts on TBXA2R and TBXAS1.

Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.

The drug

Status
Marketed
Kind
Small molecule
Brand name
Plactidil
Approvals on record
1 in 1 region
Holder of the most recent approval
Teofarma S.R.L.

US protection

No US approval on record.

With no US approval on record there are no listed US patents or exclusivities.

This is the US only.

Targets

GeneProteinUniProt
TBXA2RThromboxane A2 receptorP21731
TBXAS1Thromboxane-A synthaseP24557